Analyst Consensus ?
ConsensusBuy39 ratings
Bullish2051.3%
Neutral1948.7%
Bearish00.0%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Healthpeak Properties, Inc. analyst ratings
Healthpeak Properties, Inc. (DOC) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$20.25Current
$15Low
$20.76Average
$28High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Equal Weight | Equal Weight | Maintain | Aug 31, 2026 |
| Baird | Outperform | Outperform | Maintain | Aug 13, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 11, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 10, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 15, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 8, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 6, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jun 24, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jun 15, 2026 |
| Morgan Stanley | Equal Weight | Overweight | Downgrade | Jun 11, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | May 27, 2026 |
| Argus Research | Hold | Buy | Downgrade | Feb 5, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Feb 4, 2026 |
| Jefferies | Hold | Buy | Downgrade | Dec 16, 2025 |
| Raymond James | Outperform | Market Perform | Upgrade | Sep 15, 2025 |
| Deutsche Bank | Hold | Buy | Downgrade | Aug 20, 2025 |
| Wedbush | Outperform | Outperform | Maintain | Apr 28, 2025 |
| B of A Securities | Buy | Underperform | Upgrade | Apr 1, 2024 |
| Keybanc | Overweight | Downgrade | Jan 5, 2024 | |
| Compass Point | Buy | Buy | Maintain | Jan 2, 2024 |
| Truist Securities | Hold | Hold | Maintain | Dec 22, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Sep 28, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 4, 2022 |
| Berenberg | Buy | Hold | Upgrade | May 20, 2021 |
| B. Riley Securities | Buy | Buy | Maintain | May 7, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Apr 22, 2020 |
| BTIG Research | Neutral | Buy | Downgrade | Mar 16, 2020 |
| BTIG | Neutral | Buy | Downgrade | Mar 15, 2020 |
| B. Riley FBR | Buy | Buy | Maintain | Feb 27, 2020 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Nov 26, 2019 |
| Stifel | Buy | Hold | Upgrade | Nov 25, 2019 |
| Capital One Financial | Equal Weight | Overweight | Downgrade | May 2, 2019 |
| Capital One | Equal Weight | Overweight | Downgrade | May 1, 2019 |
| Bank of America | Buy | Buy | Maintain | Mar 8, 2018 |
| Hilliard Lyons | Buy | Long Term Buy | Maintain | Nov 5, 2017 |
| JMP Securities | Market Perform | Outperform | Downgrade | Jun 21, 2016 |
| FBR Capital | Outperform | Outperform | Maintain | Feb 29, 2016 |
| Wunderlich | Buy | Buy | Maintain | May 21, 2014 |
| Wunderlich Securities | Buy | Buy | Maintain | May 20, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $20.24. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $24 | $20.96 | +18.5% | Aug 31, 2026 |
| Cantor Fitzgerald | Richard Anderson | $23 | $21.52 | +13.6% | Aug 6, 2026 |
| Wells Fargo | Analyst unavailable | $22 | $21.66 | +8.7% | Jul 15, 2026 |
| Barclays | Analyst unavailable | $23 | $21.75 | +13.6% | Jul 7, 2026 |
| Mizuho Securities | Vikram Malhotra | $24 | $21.86 | +18.5% | Jul 6, 2026 |
| BMO Capital | Analyst unavailable | $24 | $20.69 | +18.5% | Jun 15, 2026 |
| Morgan Stanley | Ronald Kamdem | $22 | $20.76 | +8.7% | Jun 11, 2026 |
| Scotiabank | Analyst unavailable | $21 | $20.06 | +3.7% | May 27, 2026 |
| Morgan Stanley | Ronald Kamdem | $20 | $19.7 | -1.2% | May 22, 2026 |
| UBS | Analyst unavailable | $19 | $19.78 | -6.1% | May 13, 2026 |
| Morgan Stanley | Analyst unavailable | $18 | $15.83 | -11.1% | Apr 28, 2026 |
| UBS | Analyst unavailable | $17 | $17.37 | -16.0% | Apr 20, 2026 |
| Wells Fargo | John Kilichowski | $18 | $16.92 | -11.1% | Feb 3, 2026 |
| Goldman Sachs | Analyst unavailable | $17 | $17.04 | -16.0% | Jan 9, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $17 | $16.16 | -16.0% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $17 | $16.66 | -16.0% | Dec 15, 2025 |
| Evercore ISI | Analyst unavailable | $21 | $16.8 | +3.7% | Dec 15, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $20 | $19.15 | -1.2% | Oct 1, 2025 |
| Evercore ISI | Analyst unavailable | $22 | $18.08 | +8.7% | Sep 15, 2025 |
| Raymond James | Jonathan Hughes | $20 | $18.25 | -1.2% | Sep 15, 2025 |
| Morgan Stanley | Analyst unavailable | $21 | $17.75 | +3.7% | Aug 22, 2025 |
| Robert W. Baird | Analyst unavailable | $21 | $17.22 | +3.7% | Jul 30, 2025 |
| Deutsche Bank | Omotayo Okusanya | $28 | $22.64 | +38.3% | Oct 21, 2024 |
| Citigroup | Nick Joseph | $22 | $21.89 | +8.7% | Aug 21, 2024 |
| Robert W. Baird | Wesley Golladay | $24 | $21.85 | +18.5% | Jul 30, 2024 |
| RBC Capital | Michael Carroll | $25 | $21.85 | +23.5% | Jul 30, 2024 |
| Wedbush | Richard Anderson | $22 | $19.17 | +8.7% | May 3, 2024 |
| RBC Capital | Michael Carroll | $22 | $19.34 | +8.7% | Apr 10, 2024 |
| Robert W. Baird | Analyst unavailable | $22 | $18.31 | +8.7% | Mar 27, 2024 |
| Wells Fargo | Connor Siversky | $19 | $17.54 | -6.1% | Mar 25, 2024 |
| Credit Suisse | Omotayo Okusanya | $15 | $14.64 | -25.9% | Aug 1, 2023 |
| Morgan Stanley | Analyst unavailable | $16.5 | $16.95 | -18.5% | Aug 31, 2022 |
| Morgan Stanley | Analyst unavailable | $16 | $16.76 | -21.0% | Jul 15, 2022 |
| Truist Financial | Analyst unavailable | $17 | $16.58 | -16.0% | Jul 11, 2022 |
| Jefferies | Analyst unavailable | $20 | $17.58 | -1.2% | Jun 30, 2022 |
| Morgan Stanley | Analyst unavailable | $17.5 | $18.55 | -13.6% | Jun 1, 2022 |
| Barclays | Analyst unavailable | $20 | $17.58 | -1.2% | Apr 26, 2022 |
| Truist Financial | Michael R Lewis | $19 | $17.26 | -6.1% | May 6, 2021 |
Track every rating change on DOC the moment it posts. Free to start.
Start free